Jodie Danko

Director, US Patient Access at Spark Therapeutics, Inc.

Speaker

Jodie Danko is the Director of US Patient Access for Spark Therapeutics, where she is responsible for spearheading patient access to the first FDA approved gene therapy, LUXTURNA for patients in the US.

Jodie has more than 20 years of strategic commercialization experience, spanning from large pharmaceutical companies to start-up organizations. Prior to joining Spark Therapeutics in 2017, Jodie was a Regional Director of Sales at Alexion Pharmaceutics where she led the commercial rare disease market development strategy and sales force for the Central US. Jodie began her career at Sanofi Pharmaceuticals before joining start-up organizations, where she built sales functions from the ground up. Her experience spans the commercial sphere, including global training and development, sales leadership, patient journey, and patient access.

Jodie holds a Bachelor of Science in Clinical Laboratory Science from Michigan State University. She lives in Rochester, Michigan with her husband and two daughters. She enjoys summertime boating with her family on the Great Lakes and vacationing to sunny warm beaches to escape the Michigan winter.